戻る Agenda
Patient Engagement in Study Endpoints: Will the Rising Tide Lift All Boats?
Session Chair(s)
Emuella Flood
Director, Patient-Reported Outcomes
AstraZeneca, United States
It is clear that patients should be involved in the identification of relevant study endpoints, and the appropriate measurement of those endpoints. Less clear is how to ensure that patient-centric endpoints are driven through the different stakeholder environments, integrated into routine clinical care, and communicated in relevant forums. The content hub will comprise a facilitated discussion between a member of the Patient Engagement community and a member of the Study Endpoints community. Each will respond to some pre-prepared questions (e.g. how do you define patient endpoint involvement; does it make a difference with the different stakeholders) and then take questions from the floor.